13 Dec 2013:
Type VI secretion systems (T6SS) are a class of macromolecular secretion machines that are utilized by a number of bacteria for inter-bacterial competition or to elicit responses in eukaryotic cells. Acinetobacter baumannii is an opportunistic pathogen that causes severe infections in humans. These infections, including pneumonia and bacteremia, are important, as they are often associated with hospitals and medical-settings where they disproportionally affect critically ill patients like those residing in intensive care units. While it is known that A. baumannii genomes carry genes whose predicted products have homology with T6SS-associated gene products from other bacteria, and secretion of a major T6SS structural protein Hcp has been demonstrated, no additional work on an A. baumannii T6SS has been reported. Herein, we demonstrated that A. baumannii strain M2 secretes Hcp and this secretion was dependent upon TssB, an ortholog of a bacteriophage contractile sheath protein, confirming that strain M2 produces a functional T6SS. Additionally, we demonstrated that the ability of strain M2 to out-compete Escherichia coli was reliant upon the products of tssB and hcp. Collectively, our data have provided the first evidence demonstrating function in inter-bacterial competition, for a T6SS produced by A. baumannii.
Citation:Carruthers MD, Nicholson PA, Tracy EN, Munson RS Jr (2013) Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition. PLoS ONE 8(3): e59388. doi:10.1371/journal.pone.0059388
Editor: Eric Cascales, Centre National de la Recherche Scientifique, Aix-Marseille Université, France
Received: December 3, 2012; Accepted: February 14, 2013; Published: March 19, 2013
Copyright: © 2013 Carruthers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding:This research was supported by discretionary funds to RSM from The Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Acinetobacter baumannii are Gram-negative opportunistic human pathogens that have emerged as an important cause of severe nosocomial infections, which are becoming increasingly difficult to treat due to antibiotic resistance , . While many of the members of the genus Acinetobacter are commonly found in soil, aquatic environments and on human skin, the specific natural reservoir(s) for A. baumannii remain(s) to be defined . Infections caused by A. baumannii such as ventilator-associated pneumonia and surgical site infections generally occur in immune compromised patients, often with adverse outcomes . To date, there are a limited number of reports that focus on the mechanisms by which A. baumannii colonizes surfaces and causes disease , , . The reports include identification of a phospholipase D produced by A. baumannii that plays a role in serum resistance . Acinetobacter baumannii ATCC19606T relies upon an acinetobactin-mediated iron acquisition system to persist in the host and cause apoptosis in epithelial cells . The A. baumannii K1 capsule confers significantly improved growth in human ascites fluid, human serum resistance and survival in a rat soft-tissue infection model . Outer membrane protein A has been shown to play a role in biofilm formation , induce toxicity in eukaryotic cells  and mediate adherence to epithelial cells , . The A. baumannii biofilm associated protein been shown to play a role in biofilm formation and is thought to play a role in A. baumannii association with human cells in vitro . Acinetobacter baumannii 19606T produces Csu pili, which mediate adherence to and biofilm formation on abiotic surfaces . Despite these advances, we have a limited understanding of A. baumannii biology both in and around the human host.
Type VI secretion systems (T6SS) are a class of macromolecular secretion machines, analogous to the tail assembly of contractile bacteriophages , , which can facilitate the injection of effector proteins into target cells. Injection of effectors via T6SS into eukaryotic cells has been linked to phenotypes such as inhibition of phagocytosis  and induction of apoptosis , which could potentially explain the link between T6SS in certain bacteria and virulence –.
T6SS also have a role in competition between bacterial species through the contact dependent injection of effectors, which may have bacteriostatic or bactericidal activities, in target bacteria –. Mougous and colleagues have identified  and characterized  3 toxic T6SS secreted effectors (Tse1, Tse2, Tse3) produced by Pseudomonas aeruginosa. Tse2 is toxic to both bacteria and eukaryotic cells through a yet to be determined mechanism when expressed in the absence of its cognate immunity protein Tsi2. Tse1 and Tse3 have been shown to be toxic to bacteria. Russell et al. demonstrated that the most logical scenario for Tse1 and Tse3 toxicity is that these proteins are injected into a target bacterium’s periplasm, via T6SS, where Tse1 and Tse3 can then degrade peptidoglycan resulting in a comprised sacculus, which leads to cell lysis .
T6SS are comprised of at least 13 core proteins, which are widely conserved across known T6SS, and required for both T6SS biogenesis and function , . The most notable of these proteins, due to its abundance in culture supernatants of T6SS expressing bacteria, is Hcp . Hcp and orthologs are related to the major phage tail protein, gpV . In vitro, Hcp can assemble into hexameric units that can subsequently assemble together –. Thus, it is possible that Hcp forms the filamentous tube-like structures that have been observed in association with the T6SS apparatus, similar to the T4 bacteriophage tail filament, which may facilitate passage of effectors from the initiating cell to the target cell . Another core T6SS protein, TssB (VipA) is thought to be functionally analogous to a subunit of the T4 bacteriophage contractile sheath that, in complex with TssC and additional proteins, contracts to generate the mechanical force necessary to puncture biological membranes with the Hcp tube , .
It has recently been appreciated that the genomes of Acinetobacter spp. carry genes, which may encode components of T6SS , . Hcp has been isolated and identified from A. baumannii 19606T culture supernatants, indicating that the T6SS in this strain may be functional . A role of for this A. baumannii T6SS has not been reported.
In this work, we identified a cluster of 20 genes and 3 additional genes carried on the chromosome of A. baumannii strain M2 that, together, are predicted to encode a T6SS. We observed that Hcp was a major protein component of strain M2 culture supernatants and secretion of Hcp was reliant upon the gene that is predicted to encode a T6SS sheath protein, TssB. These results indicated that strain M2 produced a functional T6SS. Further, we demonstrated that A. baumannii out-competes Escherichia coli in a T6SS- and contact-dependent manner. Overall, the data presented herein provide evidence for expression of a T6SS by A. baumannii M2 and demonstrate a role for this system in bacterial competition.
Materials and Methods
Bacterial Strains and Culture Conditions
All strains and plasmids are listed in Table 1. Acinetobacter baumannii strain M2, a clinical isolate from Cleveland Metro-Health Systems obtained from Philip Rather at Emory University, was used in this study . All bacterial strains were grown on L-agar or L-broth prior to experimentation. Antibiotics were added to A. baumannii cultures, where appropriate, at the following concentrations in µg/ml: kanamycin, 20; chloramphenicol, 12.5; or ampicillin, 750. Escherichia coli cultures were supplemented with antibiotics at the following concentrations in µg/ml: kanamycin, 20; streptomycin, 25 or ampicillin, 50.
Bioinformatic Screen for T6SS Genes in A. baumannii Strain M2
The incomplete genome of A. baumannii strain M2 (Munson and Rather, unpublished) was screened for genes and/or proteins that showed sequence identity to genes or proteins associated with T6SS. T6SS genes and gene clusters were identified based on protein identity (NCBI BLAST, ), presence of conserved domains (NCBI Conserved Domains Search, ), and PHYRE2  structural predictions compared to T6SS proteins in several bacteria.
Recombinant DNA Methodologies
Primers, obtained from Integrated DNA Technologies (Coralville, IA), are listed in Table S1. We constructed unmarked in-frame deletions of tssB and hcp in the A. baumannii strain M2 chromosome essentially as was done for the construction of nontypeable Haemophilus influenzae mutants by Tracy et al . This method uses the bacteriophage λ recombinase system to delete the gene of interest, replacing it with an FRT-kan-sacB-FRT cassette in a plasmid containing the gene of interest as well as flanking chromosomal DNA. This construct was used as a template for PCR and the amplicon used to transform M2. Subsequently, the cassette is removed by introduction of a suicide plasmid expressing the FLP recombinase into the mutant, which catalyzes a site-specific recombination event resulting in loss of the cassette. To construct strain M2 with an un-marked in-frame deletion of hcp, we amplified the strain M2 hcp gene and flanking sequence with primer set 4, then cloned the amplicon into pGEM-T-Easy (Promega, Madison, WI). An amplicon was also generated from pRSM3542 (construction described in Text S1) using primer set 3. This amplicon contained the FRT-kan-sacB-FRT region flanked on one side by 47 bp 5′ of hcp as well as the translational ATG start and on the other side by the last 21 bp of hcp and 29 bp downstream of hcp. The amplicon and the plasmid containing hcp were electroporated into E. coli DY380, which had been heat shocked at 42°C for 15 min prior to electroporation to induce expression of the λ recombinase system, then clones were selected on kanamycin-containing L-agar plates. Plasmids were isolated and characterized; a plasmid containing the FRT-kan-sacB-FRT cassette in place of hcp was saved as pGEM-Δhcp::kan-sacB. An amplicon was generated with primer set 4 and pGEM-Δhcp::kan-sacB as template, and the mutation was introduced into the M2 genome by natural transformation. Transformation in strain M2 was performed by incubating 1 µg of the amplicon with 500 µl of a strain M2 culture grown 2 h from a 1:10 dilution of an overnight culture. This mixture was transferred to a L-agar plate and incubated at 37°C for 4 h. Cells were scraped from the plate into 500 µl of L-broth and dilutions were plated on L-agar containing 20 µg/ml of kanamycin. Genomic DNA was isolated from kanamycin resistant colonies, amplicons were prepared using primer set 4 and the allele exchange was confirmed by sequencing. A single clone was saved as M2Δhcp::kan-sacB. pFLP2 , a suicide plasmid carrying the FLP recombinase was mated into M2Δhcp::kan-sacB. Briefly, matings were performed by mixing 100 µl of each of stationary cultures normalized to an OD600 of 2.0 of the recipient strain (M2Δhcp::kan-sacB), the helper strain E. coli HB101(pRK2013), E. coli DH5α (pFLP2) to 700 µl of warm L-broth pre-incubated at 32°C. This mixture was washed twice in 32°C L-broth followed by centrifugation at 7,000×g. After the final wash, the pellet was resuspended in 25 µl of 32°C L-broth and this suspension was spotted onto a pre-warmed L-agar plate and incubated overnight at 32°C. Plates were then moved to a 37°C incubator for 2 h to induce the FLP recombinase. Post-incubation, bacteria were swabbed from the agar surface and resuspended in 1 ml L-broth, vortexed on high for 8 sec and serial dilutions were plated on L-agar containing 12.5 µg of chloramphenicol and 10% sucrose. Plates were incubated at room temperature overnight. Strain M2 is resistant to chloramphenicol and was thus used to select against the E. coli donor in the mating mixture. The sacB gene product confers sucrose sensitivity to strain M2 growing at room temperature. Sucrose resistant and kanamycin sensitive clones were identified then analyzed by PCR and sequencing to confirm that the cassette was excised, resulting in an unmarked in-frame deletion. A single clone with the correct sequence was saved as M2Δhcp. This procedure was followed to construct strain M2ΔtssB with an unmarked mutation in tssB, using primer sets 5 and 6 to make pGEM-tssB and pGEM-ΔtssB::kan-sacB respectively.
Complementation was performed using a mini-Tn7 transposon system. A suicide vector that carries mini-Tn7-Ap, pRSM3510, was constructed as described in the Text S1. pRSM3510 constructs were introduced into A. baumannii via a four parental conjugal mating strategy modified from Kumar et al. . Briefly, 100 µl of stationary cultures normalized to an OD600 of 2.0 of the recipient strain (A. baumannii mutants), E. coli HB101(pRK2013), E. coli EC100D(pTNS2) and E. coli EC100D(pRSM3510) were added to 600 µl of L-broth pre-incubated at 37°C. This mixture was washed twice in warm L-broth followed by centrifugation at 7,000×g. After the final wash, the pellet was resuspended in 25 µl of 37°C L-broth and this suspension was spotted onto a 37°C L-agar plate and incubated overnight at 37°C. Bacteria were then swabbed from the agar surface and resuspended in 1 ml L-broth, vortexed on high for 8 sec and serial dilutions were plated on L-agar containing ampicillin (750 µg/ml) and chloramphenicol (12.5 µg/ml) to select for A. baumannii cells containing mini-Tn7-Ap constructs integrated into the chromosome. To verify insertion downstream of glmS2, primer set 9 was used in PCR to amplify a 400 bp product that spans both downstream of glmS2 and a portion of mini-Tn7-Ap. A clone with the correct sequence was saved as M2ΔtssB(tssB+).
Growth Curve and Assay for Hcp Secretion
Acinetobacter baumannii strains were inoculated into 25 ml of L-broth in a 250 ml Erlenmeyer flask at an A600 of 0.05 and incubated at 37°C, 180 rpm. For growth curves, A600 was measured hourly for 6 h. To assay for Hcp secretion, cultures were grown until stationary phase (A600 ~2.5) was reached. Cleared supernatants were obtained by centrifugation of cultures at 4,000×g, 4°C for 20 min followed by centrifugation of the resultant supernatant at 100,000×g, 4°C for 2 h. Twenty milliliters of cleared supernatants were concentrated 20-fold by filtration through Ultracel 10K centrifuge filters (EMD Millipore, Billerica, MA) according to the manufacturers protocol. The recovered concentrated cell supernatants were analyzed by SDS-PAGE as described below. Mass spectrometry was performed by The Ohio State University Mass Spectrometry and Proteomics Facility.
SDS-PAGE and Western Blot Analysis
Protein separation was carried out by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) as previously described . Briefly, samples were mixed with an equal volume of 2× Laemmli sample buffer (Bio-Rad), boiled for 10 min, and cooled to room temperature. Samples were resolved on 4–20% Mini-Protean TGX Precast gels (Bio-Rad). Where needed, proteins were transferred from SDS-PAGE gels to nitrocellulose membranes as described by Tobwin et al. . Membranes were blocked for 1 h with SuperBlock T20 (Thermo Fisher Scientific, Rockford, IL). A mouse α-Hcp6 antibody  at a dilution of 1/15,000 in Superblock T20 was used as a primary antibody for detection of Hcp. A horseradish peroxidase conjugated goat α-mouse secondary antibody (Thermo Fisher Scientific) at a dilution of 1:5000 in Superblock was used followed by visualization of Hcp using the SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) according to manufacturers instructions. Between application of secondary antibody and detection, nitrocellulose membranes were washed 3×5 min with tris-buffered saline with 0.05% Tween-20.
Bacterial Competition Assays
Overnight L-broth cultures of bacterial strains were used to inoculate 25 ml of L-broth in 250 ml Erlenmeyer flasks to an A600 of 0.05. Cultures were incubated at 37°C, 180 rpm till an A600 of ~0.5–0.6 was reached. Cultures were then diluted to an A600 of 0.4. For competition, 40 µl of A. baumannii was mixed with 4 µl of the competitor, E. coli, and 20 µl of this mixture was spotted on a pre-warmed agar L-agar plate. Plates were incubated at 37°C for 4 hr. Post-incubation, spots were excised from the plate, placed in a 14 ml culture tube containing 500 µl of PBS, vortexed for 5 s and serial diluted. Dilutions were plated on L-agar containing chloramphenicol to select for A. baumannii strains and on L-agar containing streptomycin to select for E. coli DH10B. In competition experiments with E. coli and A. baumannii strains separated by a filter, 20 µl of one strain was spotted on the agar surface, a 0.22 µm pore isopore filter (EMD Millipore) was placed on this spot and 20 µl of the other strain was spotted on top of the filter.
Statistical analyses were performed using non-parametric one-way analysis of variance (Kruskall-Walis). Post-hoc analysis was performed using Dunn’s multiple comparison test and a P-value <0.05 was considered to be statistically significant. Analyses were performed using GraphPad Prism version 6.0a (La Jolla, CA).
Identification of a T6SS in A. baumannii Strain M2
While there is a proposed nomenclature for the genes encoding T6SS produced by Acinetobacter (ass) , in this manuscript we use the recently adopted standard T6SS nomenclature (tss) . A draft sequence of the of A. baumannii strain M2 genome was generated (data not shown) and the resultant contig set was screened for genes and/or proteins that showed sequence homology to genes or proteins associated with T6SS. This targeted search resulted in the identification of a gene cluster of 18 open reading frames. Together with 3 additional genes outside of the cluster, we identified genes that are predicted to encode 12 of the 13 core T6SS proteins (Tss, Hcp and VgrG), 2 proteins associated with T6SS in other bacteria (Tag) and 5 proteins that appear to be encoded only in Acinetobacter spp. (Asa) (Genbank Accession KC432605-KC432608). A protein with identity to the core T6SS protein TssJ was not detected in the strain M2 predicted proteome. The genetic organization of the A. baumannii T6SS gene cluster, depicted in Figure 1, appears to be conserved amongst sequenced A. baumannii strains and is similar to the of T6SS gene cluster of A. baylyi ADP1 with the exception that a portion of the gene cluster is inverted (data not shown). The tssB and hcp genes, which are predicted to encode a putative T6SS sheath protein and the T6SS tube protein respectively, were chosen for mutational analysis.
A single ~23 kb gene cluster, asaA-tssBC-hcp-tssEFG-asaB-tssM-tagFN-asaC-tssHAKL-asaDE carries 18 putative genes predicted to encode for components of a T6SS. The genome of A. baumannii strain M2 carries genes that are predicted to encode 12 of the 13 core T6SS proteins (tss, colored scarlet), 2 proteins with homology to T6SS-associated proteins in other bacteria (tag, colored black) and 5 proteins encoded by genes only identified in A. baumannii T6SS gene clusters (asa, Acinetobacter type six secretion system-associated, colored gray). Three additional genes whose products have homology to VgrG were identified in other regions of the genome (data not shown).
Construction and Characterization of Unmarked In-frame Insertion/deletion Mutants Lacking the tssB and hcp Genes in Strain M2
We used a modification of methods developed for use in E. coli by Wanner and co-workers  that employed both the bacteriophage λ recombination system as well as the yeast FLP recombinase system. In E. coli, the bacteriophage λ recombinase will catalyze site-specific recombination with 50 bp of homologous DNA. The FLP recombinase was used to delete DNA flanked by 2 FLP recombinase recognition sites (FRT). A mutant was constructed which contains sequences 5′ of the deleted gene, followed by short ORF containing the ATG start of the deleted gene, the single remaining FRT site and the last 21 nt of the deleted gene, followed by sequences 3′ to the gene. The 3′ portion of the deleted gene is retained to preserve the Shine-Dalgarno sequence 5′ of the downstream gene. Mutants with unmarked, in-frame deletions in the tssB and hcp genes were constructed and the deletions confirmed by sequencing.
Acinetobacter baumannii Strain M2 Secreted Hcp
A hallmark of a functional T6SS is the secretion of Hcp . To first determine if A. baumannii strain M2 produced a functional T6SS, we assessed the ability of the tssB and hcp mutants to secrete Hcp. The growth curves of strains M2, M2ΔtssB and M2Δhcp were similar (Figure 2.A) indicating that tssB and hcp mutations did not significantly alter growth kinetics. To assay for Hcp secretion concentrated cell supernatants were prepared from stationary phase cultures of strain M2, the isogenic tssB and hcp mutants and the tssB complemented tssB mutant. The predominant band in concentrated cultures supernatants prepared from strain M2, as detected by SDS-PAGE and Coomassie staining, had the approximate molecular mass of Hcp (Figure 2.B) and was identified as Hcp by mass spectroscopy. In addition, the band was absent in samples prepared from cultures strains of M2ΔtssB and M2Δhcp. An antibody that was generated against Hcp6 from Burkholderia pseudomallei  was used for Western blot analysis to determine the presence Hcp in whole cells and concentrated culture supernatants. Hcp was detected in whole cells of strain M2, M2ΔtssB and the complemented tssB mutant, but not in M2Δhcp. In addition, Hcp was detected in concentrated culture supernatants of strain M2 and the complemented tssB mutant, but not in the tssB and hcp mutants. Attempts to detect Hcp secretion in the complemented hcp mutant were unsuccessful, indicating that this mutation may be polar on down-stream genes in the T6SS gene cluster. The presence of Hcp in culture supernatants and the reliance of Hcp secretion on a homolog of a core T6SS component (TssB) indicated that the strain M2 T6SS was functional and active under the conditions described above.
A. Growth curves of strain M2 and the isogenic tssB and hcp mutants. Three biological replicates were performed; error bars denote the standard error of the mean of the biological replicates. B. Concentrated culture supernatants from strain M2, M2ΔtssB and M2Δhcp analyzed by SDS-PAGE and Coomassie staining. A band corresponding to the approximate molecular mass of Hcp (~19 kDa), indicated by the arrow, was observed in the sample derived from strain M2 and was absent in the samples from M2ΔtssB and M2Δhcp. Mass spectrometry confirmed that the major protein in this band was Hcp. C. Western blot analysis of whole cell lysates and concentrated culture supernatants of A. baumannii strains. Hcp, indicated by the arrow, was detected in whole cell lysates of strain M2, M2ΔtssB and the complemented tssB mutant as well as in concentrated culture supernatants of strain M2 and the complemented tssB mutant.
Acinetobacter baumannii Out-competed E. coli in a T6SS-dependent Manner
Since bacteria can use T6SS to compete with other bacteria and our results indicated that strain M2 expresses a functional T6SS, we hypothesized that strain M2 may utilize a T6SS to facilitate inter-bacterial competition. To study a potential role of A. baumannii T6SS in bacterial competition, we mixed A. baumannii strain M2 and E. coli DH10B at a 10:1 ratio respectively, spotted this mixture onto L-agar and after 4 h of incubation, spots were excised and surviving A. baumannii and E. coli were assessed by spotting dilutions on L-agar plates with antibiotics and CFU determination. After competition with strain M2, a surviving E. coli population was not detected, while the surviving E. coli population from competitions with either M2ΔtssB or M2Δhcp was equivalent to the no treatment control population (Figure 3.A). Quantitatively, a 5.3-log reduction (P<0.0001) in E. coli CFU was observed after co-incubation with strain M2 compared to the no treatment control. No difference was observed between the surviving E. coli populations that received no treatment or when co-incubated with M2Δhcp (Figure 3.B). All M2 strains grew to similar population densities when spotted on L-agar and with or without co-incubation with E. coli (Figure 3.B). These results indicate that A. baumannii produces a functional T6SS, which plays a role in competition with bacteria.
A. Semi-quantitative assessment of surviving E. coli after 4 h mixed with media (Control) or at a 10:1 ratio (10 A. baumannii to 1 E. coli) with A. baumannii strain M2, M2ΔtssB or M2Δhcp. B. Quantitative assessment of the A. baumannii and E. coli DH10B populations. Data represent of 3 biological replicates each performed in duplicate. Error bars represent standard error of the mean of the biological replicates. * Indicates a significant difference (P<0.0001) between E. coli CFU observed with or without co-incubation with strain M2. The dotted line on each bar graph of panel B indicates level of detection.
Acinetobacter baumannii T6SS-mediated Competition was Contact Dependent
In order to further confirm that the ability of A. baumannii to out-compete E. coli was T6SS dependent, a competition experiment was performed that utilized a 0.22 µm pore filter separating strain M2 and E. coli. When strain M2 and E. coli were mixed and spotted on top of a filter (Figure 4), a ~6-log reduction (P<0.01) in the E. coli population was observed when compared to all other groups. In addition, the E. coli populations incubated above or below the filter were similar, which indicated that the location of E. coli above or below the filter did not impact viability. When separated by the filter, no competition between strain M2 and E. coli was observed (Figure 4). These results provide additional evidence that A. baumannii uses a T6SS in inter-bacterial competition, as competition was not only dependent upon the tssB and hcp gene products, but was also contact dependent.
Qualitative assessment of E. coli DH10B populations after 4 h of competition with the indicated A. baumannii strains or media. The backslash between strains (E.c. = E. coli, M2 = strain M2) or L (L-broth) indicate the presence of a 0.22 µm pore filter. Data represent 3 biological replicates performed in duplicate. Error bars represent standard error of the mean of the biological replicates. * Indicates a significant difference (P<0.01) in E. coli CFU between the M2+E.c./L group when compared to all other groups.
T6SS-associated genes have been identified previously in other Acinetobacter spp.  and in A. baumannii specifically , but a function for these T6SS was not elucidated. In this study, we provided the first evidence assigning a function to the A. baumannii T6SS in inter-bacterial competition.
Analysis of concentrated culture supernatants showed that the T6SS structural and effector protein, Hcp, accumulated in supernatants of cultures of A. baumannii strain M2 grown under standard laboratory conditions, and was the predominant protein species observed by Coomassie-stained SDS-PAGE of culture supernatants (Figure 2.B). In addition, Hcp secretion was dependent upon tssB, a gene that is predicted to encode a T6SS sheath protein that is required for T6SS function in other bacteria . Western blot analysis confirmed secretion of Hcp into the culture supernatant of strain M2 and the complemented hcp mutant, which indicated that the tssB mutation did not affect expression of the downstream hcp gene. In addition, the tssB mutant produced Hcp but was unable to secrete it (Figure 2.C). Attempts to complement the Hcp secretion phenotype in the hcp mutant were unsuccessful. This is likely due to polar effects on down stream genes in the T6SS gene cluster. As secretion of Hcp is the hallmark of a functional T6SS , these results indicated that A. baumannii strain M2, indeed, does produce a functional T6SS. We assume, as has been postulated by others, that detection of Hcp in culture supernatants was due to Hcp being sheared off from the surface of cells that express T6SS , .
In order to identify a function for the A. baumannii T6SS we assessed the potential of strain M2 and the isogenic tssB and hcp mutants to outcompete E. coli. In this assay, strain M2 elicited a 5.3-log decrease in E. coli CFU during co-incubation, which was tssB and hcp-dependent (Figure 3). The CFU of A. baumannii strains was unaffected by co-incubation with E. coli (Figure 2.B). These data are similar to those reported for T6SS-dependent competition-phenotypes of Serratia marcescens, Vibrio cholerae and P. aeruginosa –, strongly supporting the role for the A. baumannii T6SS in bacterial competition.
The T6SS-dependent competition between strain M2 and E. coli was observed, by a 6-log reduction in E. coli CFU when mixed and incubated together above a filter with 0.22 µm pores (Figure 4). Competition was abrogated when strain M2 and E. coli were separated by a filter. These results indicated that competition between A. baumannii and E. coli was dependent on cell-to-cell contact. In other systems, the antibacterial action mediated by T6SS has also been shown to be contact dependent . These data provide further evidence that A. baumannii competition with E. coli was, indeed, mediated by a T6SS.
A small number of T6SS effectors, exhibiting toxicity against bacteria have been identified. In Pseudomonas aeruginosa, for example, the toxic effectors, Tse1, Tse2 and Tse3 are injected into target cells via a T6SS . Tse1 and Tse3 are active in the periplasm and have been shown to cleave peptidoglycan. Cells expressing the cognate immunity proteins to Tse1 and Tse3, Tsi1 and Tsi2, are protected from these effects. Tse2 appears to cause quiescence when expressed in the cytoplasm in the absence the Tse2 immunity protein, Tsi2 . In S. marcescens, the T6SS effectors Ssp1 and Ssp2 are toxic to target bacteria when localized to the periplasm in the absence of the immunity proteins Rap1a and Rap2a respectively. The mechanism behind the effect Ssp1 and Ssp2 has on target bacteria has yet to be elucidated . We and others have attempted to identify potential T6SS effectors in A. baumannii strains using bioinformatics approaches. Russell et al., using a heuristic method, identified a potential effector . This predicted T6SS effector was found in one A. baumannii strain, strain SDF, encoded by a gene carried on a plasmid that is not conserved amongst Acinetobacter spp. Thus, the specific mechanism behind T6SS-dependent inter-bacterial competition in A. baumannii remains unclear.
The ability to compete with other bacteria, via T6SS, could be important both in and ex vivo for the success of A. baumannii as a pathogen. One can imagine a ventilation tube in an intubated patient becoming colonized with a variety of bacteria including A. baumannii. In order to colonize this surface, thrive and eventually cause disease in the patient, it is logical to assume these bacteria would compete for this niche. Similarly, in patients with infected wounds or that are afflicted with pneumonia; a mixed population of bacteria at these sites would compete to maintain the species. We postulate that A. baumannii utilizes its T6SS to compete with bacteria in these environments. With respect to the role of T6SS in disease, specifically T6SS-mediated interactions with eukaryotic cells, we welcome the idea that the A. baumannii T6SS plays a direct role in virulence but, as of yet, do not have evidence for such a role.
In conclusion, we have provided evidence that the A. baumannii T6SS is functional and that it plays a role in competition with other bacterial species. The specific mechanism behind this competition has yet to be elucidated. Additional studies are needed to determine if the T6SS produced by A. baumannii confers a fitness advantage, when faced with bacterial competitors during the course of colonization and disease. The study of biogenesis, function and regulation of A. baumannii T6SS, although in its infancy, has the potential to make a significant impact on our understanding of how A. baumannii may persist amongst mixed populations during survival in the medical environment or during the course of disease.
During revision of this manuscript, Weber et al. described the type VI secretion system in A. baumannii ATCC 17978 . Although the gene clusters characterized by both laboratories are very similar, Weber et al. did not observe Type VI secretion system-dependent killing of E. coli. Additional work will be required to identify the basis for the differences observed in the two studies.
We would like to thank Beth Baker for her technical assistance. Plasmids pFLP2 and pUC18T-Tn7-Gm were gifts from Dr. Herbert Schweizer. pKNOCK, E. coli HB101(pRK2013), E. coli EC100D(pTNS2) were gifts from Dr. Luis Acits. Antisera directed against Burkholderia pseudomallei Hcp6 was a generous gift from Dr. David Deshazer.
Conceived and designed the experiments: MDC RSM PAN. Performed the experiments: MDC PAN ENT. Analyzed the data: MDC PAN ENT RSM. Wrote the paper: MDC RSM.
- 1. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538–582. doi: 10.1128/cmr.00058-07
- 2. Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939–951. doi: 10.1038/nrmicro1789
- 3. Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ (2007) Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 26: 793–800. doi: 10.1007/s10096-007-0371-8
- 4. McConnell MJ, Actis L, Pachon J (2012) Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev.
- 5. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, et al. (2012) The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One 7: e46984. doi: 10.1371/journal.pone.0046984
- 6. Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, et al. (2010) Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 78: 1952–1962. doi: 10.1128/iai.00889-09
- 7. Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Pachon J, et al. (2012) Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun 80: 1015–1024. doi: 10.1128/iai.06279-11
- 8. Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, et al. (2010) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307–0294 is a major virulence factor. Infect Immun 78: 3993–4000. doi: 10.1128/iai.00366-10
- 9. Gaddy JA, Tomaras AP, Actis LA (2009) The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 77: 3150–3160. doi: 10.1128/iai.00096-09
- 10. Choi CH, Hyun SH, Lee JY, Lee JS, Lee YS, et al. (2008) Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol 10: 309–319. doi: 10.1111/j.1462-5822.2007.01041.x
- 11. Choi CH, Lee JS, Lee YC, Park TI, Lee JC (2008) Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 8: 216. doi: 10.1186/1471-2180-8-216
- 12. Brossard KA, Campagnari AA (2012) The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun 80: 228–233. doi: 10.1128/iai.05913-11
- 13. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA (2003) Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149: 3473–3484. doi: 10.1099/mic.0.26541-0
- 14. Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, et al. (2009) Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci U S A 106: 4154–4159. doi: 10.1073/pnas.0813360106
- 15. Pell LG, Kanelis V, Donaldson LW, Howell PL, Davidson AR (2009) The phage lambda major tail protein structure reveals a common evolution for long-tailed phages and the type VI bacterial secretion system. Proc Natl Acad Sci U S A 106: 4160–4165. doi: 10.1073/pnas.0900044106
- 16. Ma AT, McAuley S, Pukatzki S, Mekalanos JJ (2009) Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells. Cell Host Microbe 5: 234–243. doi: 10.1016/j.chom.2009.02.005
- 17. Suarez G, Sierra JC, Erova TE, Sha J, Horneman AJ, et al. (2010) A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity by ADP ribosylation of actin. J Bacteriol 192: 155–168. doi: 10.1128/jb.01260-09
- 18. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 64: 1466–1485. doi: 10.1111/j.1365-2958.2007.05734.x
- 19. Mulder DT, Cooper CA, Coombes BK (2012) Type VI secretion system-associated gene clusters contribute to pathogenesis of Salmonella enterica serovar Typhimurium. Infect Immun 80: 1996–2007. doi: 10.1128/iai.06205-11
- 20. Broms JE, Meyer L, Lavander M, Larsson P, Sjostedt A (2012) DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity. PLoS One 7: e34639. doi: 10.1371/journal.pone.0034639
- 21. Hood RD, Singh P, Hsu F, Guvener T, Carl MA, et al. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7: 25–37. doi: 10.1016/j.chom.2009.12.007
- 22. MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S (2010) The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci U S A 107: 19520–19524. doi: 10.1073/pnas.1012931107
- 23. Murdoch SL, Trunk K, English G, Fritsch MJ, Pourkarimi E, et al. (2011) The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors. J Bacteriol 193: 6057–6069. doi: 10.1128/jb.05671-11
- 24. Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, et al. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475: 343–347. doi: 10.1038/nature10244
- 25. Russell AB, Singh P, Brittnacher M, Bui NK, Hood RD, et al. (2012) A widespread bacterial type VI secretion effector superfamily identified using a heuristic approach. Cell Host Microbe 11: 538–549. doi: 10.1016/j.chom.2012.04.007
- 26. Schwarz S, West TE, Boyer F, Chiang WC, Carl MA, et al. (2010) Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog 6: e1001068. doi: 10.1371/journal.ppat.1001068
- 27. Bingle LE, Bailey CM, Pallen MJ (2008) Type VI secretion: a beginner's guide. Curr Opin Microbiol 11: 3–8. doi: 10.1016/j.mib.2008.01.006
- 28. Cascales E (2008) The type VI secretion toolkit. EMBO Rep 9: 735–741. doi: 10.1038/embor.2008.131
- 29. Silverman JM, Brunet YR, Cascales E, Mougous JD (2012) Structure and Regulation of the Type VI Secretion System. Annu Rev Microbiol 66: 453–472. doi: 10.1146/annurev-micro-121809-151619
- 30. Ballister ER, Lai AH, Zuckermann RN, Cheng Y, Mougous JD (2008) In vitro self-assembly of tailorable nanotubes from a simple protein building block. Proc Natl Acad Sci U S A 105: 3733–3738. doi: 10.1073/pnas.0712247105
- 31. Jobichen C, Chakraborty S, Li M, Zheng J, Joseph L, et al. (2010) Structural basis for the secretion of EvpC: a key type VI secretion system protein from Edwardsiella tarda. PLoS One 5: e12910. doi: 10.1371/journal.pone.0012910
- 32. Osipiuk J, Xu X, Cui H, Savchenko A, Edwards A, et al. (2011) Crystal structure of secretory protein Hcp3 from Pseudomonas aeruginosa. J Struct Funct Genomics 12: 21–26. doi: 10.1007/s10969-011-9107-1
- 33. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ (2012) Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483: 182–186. doi: 10.1038/nature10846
- 34. Basler M, Mekalanos JJ (2012) Type 6 secretion dynamics within and between bacterial cells. Science 337: 815. doi: 10.1126/science.1222901
- 35. de Berardinis V, Vallenet D, Castelli V, Besnard M, Pinet A, et al. (2008) A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1. Mol Syst Biol 4: 174. doi: 10.1038/msb.2008.10
- 36. Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, et al. (2012) Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-beta-1,6-N-acetylglucosamine. Antimicrob Agents Chemother 56: 59–69. doi: 10.1128/aac.05191-11
- 37. Niu C, Clemmer KM, Bonomo RA, Rather PN (2008) Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol 190: 3386–3392. doi: 10.1128/jb.01929-07
- 38. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403–410. doi: 10.1016/s0022-2836(05)80360-2
- 39. Marchler-Bauer A, Bryant SH (2004) CD-Search: protein domain annotations on the fly. Nucleic Acids Res 32: W327–331. doi: 10.1093/nar/gkh454
- 40. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363–371. doi: 10.1038/nprot.2009.2
- 41. Tracy E, Ye F, Baker BD, Munson RS Jr (2008) Construction of non-polar mutants in Haemophilus influenzae using FLP recombinase technology. BMC Mol Biol 9: 101. doi: 10.1186/1471-2199-9-101
- 42. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 77–86. doi: 10.1016/s0378-1119(98)00130-9
- 43. Kumar A, Dalton C, Cortez-Cordova J, Schweizer HP (2010) Mini-Tn7 vectors as genetic tools for single copy gene cloning in Acinetobacter baumannii. J Microbiol Methods 82: 296–300. doi: 10.1016/j.mimet.2010.07.002
- 44. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685. doi: 10.1038/227680a0
- 45. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350–4354. doi: 10.1073/pnas.76.9.4350
- 46. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, et al. (2011) The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun 79: 1512–1525. doi: 10.1128/iai.01218-10
- 47. Shalom G, Shaw JG, Thomas MS (2007) In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology 153: 2689–2699. doi: 10.1099/mic.0.2007/006585-0
- 48. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645. doi: 10.1073/pnas.120163297
- 49. Pukatzki S, McAuley SB, Miyata ST (2009) The type VI secretion system: translocation of effectors and effector-domains. Curr Opin Microbiol 12: 11–17. doi: 10.1016/j.mib.2008.11.010
- 50. Zheng J, Ho B, Mekalanos JJ (2011) Genetic analysis of anti-amoebae and anti-bacterial activities of the type VI secretion system in Vibrio cholerae. PLoS One 6: e23876. doi: 10.1371/journal.pone.0023876
- 51. English G, Trunk K, Rao VA, Srikannathasan V, Hunter WN, et al.. (2012) New secreted toxins and immunity proteins encoded within the Type VI secretion system gene cluster of Serratia marcescens. Mol Microbiol.
- 52. Weber BS, Miyata ST, Iwashkiw JA, Mortensen BL, Skaar EP, et al. (2013) Genomic and Functional Analysis of the Type VI Secretion System in Acinetobacter. PLoS One 8: e55142. doi: 10.1371/journal.pone.0055142
- 53. Choi KH, Gaynor JB, White KG, Lopez C, Bosio CM, et al. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2: 443–448. doi: 10.1038/nmeth765
- 54. Alexeyev MF (1999) The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gram-negative bacteria. Biotechniques 26: 824–826, 828.
- 55. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56–65. doi: 10.1006/geno.2000.6451
- 56. Figurski DH, Helinski DR (1979) Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76: 1648–1652. doi: 10.1073/pnas.76.4.1648